literature on the treatment of vascular kidney disease with l-carnitine Frontiers Frontiers | Effects of L-carnitine
Description
2012;302:R49R58
Aires CCP, van Cruchten A, Ijlst L et al (2011) New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA
Our perfect, unique dietary supplements help you achieve your goals
